
SDZ 208-912 is a dual-action 5-HT1A/2 рецептор агонист and dopamine D1 рецептор антагонист. SDZ 208-912 exhibits partial dopamine agonism and atypical neurosedative effects in rodent models. SDZ 208-912 can be used in research on neurological disorders such as schizophrenia.
SDZ 208-912 is a dual-action 5-HT1A/2 receptor agonist and dopamine D1 receptor antagonist. SDZ 208-912 exhibits partial dopamine agonism and atypical neurosedative effects in rodent models. SDZ 208-912 can be used in research on neurological disorders such as schizophrenia.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.